JPMorgan Chase & Co. Increases U.S. Physical Therapy (NYSE:USPH) Price Target to $120.00

U.S. Physical Therapy (NYSE:USPH) had its price target hoisted by investment analysts at JPMorgan Chase & Co. from $117.00 to $120.00 in a report issued on Tuesday,Benzinga reports. The firm presently has an “overweight” rating on the stock. JPMorgan Chase & Co.‘s price objective indicates a potential upside of 19.43% from the company’s previous close.

USPH has been the subject of a number of other research reports. StockNews.com upgraded U.S. Physical Therapy from a “sell” rating to a “hold” rating in a report on Wednesday, August 21st. Bank of America reiterated a “neutral” rating and set a $90.00 price objective (down previously from $114.00) on shares of U.S. Physical Therapy in a research report on Monday, October 7th. Finally, Barrington Research reissued an “outperform” rating and issued a $108.00 target price on shares of U.S. Physical Therapy in a research report on Thursday, November 21st.

U.S. Physical Therapy Stock Up 1.1 %

Shares of USPH traded up $1.11 during mid-day trading on Tuesday, hitting $100.48. 16,440 shares of the company’s stock were exchanged, compared to its average volume of 93,081. The company has a debt-to-equity ratio of 0.27, a current ratio of 1.78 and a quick ratio of 1.78. U.S. Physical Therapy has a 52 week low of $76.18 and a 52 week high of $113.63. The company has a market cap of $1.52 billion, a PE ratio of 106.89, a P/E/G ratio of 4.47 and a beta of 1.46. The company has a 50-day simple moving average of $86.93 and a 200 day simple moving average of $90.29.

Insider Buying and Selling at U.S. Physical Therapy

In other U.S. Physical Therapy news, Director Nancy Ham sold 1,172 shares of the firm’s stock in a transaction that occurred on Friday, November 8th. The stock was sold at an average price of $96.72, for a total value of $113,355.84. Following the completion of the sale, the director now owns 1,112 shares of the company’s stock, valued at approximately $107,552.64. This trade represents a 51.31 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, Director Bernard A. Harris, Jr. sold 2,000 shares of the company’s stock in a transaction that occurred on Tuesday, November 12th. The stock was sold at an average price of $92.95, for a total value of $185,900.00. Following the transaction, the director now directly owns 16,726 shares in the company, valued at $1,554,681.70. The trade was a 10.68 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 6,896 shares of company stock valued at $656,940. 1.70% of the stock is currently owned by insiders.

Institutional Trading of U.S. Physical Therapy

A number of hedge funds and other institutional investors have recently bought and sold shares of the business. Geode Capital Management LLC lifted its stake in shares of U.S. Physical Therapy by 1.3% in the third quarter. Geode Capital Management LLC now owns 343,073 shares of the company’s stock valued at $29,040,000 after buying an additional 4,477 shares in the last quarter. Y Intercept Hong Kong Ltd bought a new position in U.S. Physical Therapy in the 3rd quarter valued at about $573,000. MML Investors Services LLC boosted its stake in U.S. Physical Therapy by 12.7% during the 3rd quarter. MML Investors Services LLC now owns 11,826 shares of the company’s stock valued at $1,001,000 after purchasing an additional 1,329 shares during the last quarter. Southernsun Asset Management LLC increased its holdings in U.S. Physical Therapy by 10.5% during the 3rd quarter. Southernsun Asset Management LLC now owns 547,111 shares of the company’s stock worth $46,302,000 after purchasing an additional 52,062 shares in the last quarter. Finally, State Street Corp raised its stake in shares of U.S. Physical Therapy by 17.5% in the third quarter. State Street Corp now owns 667,868 shares of the company’s stock worth $56,522,000 after purchasing an additional 99,244 shares during the last quarter.

U.S. Physical Therapy Company Profile

U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.